Anne Marie Fremin
Allergy · Hammond, LANPI 1558537001
Payments from drug & device makers
Across 160 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$846
- AstraZeneca$773
- Regeneron Healthcare Solutions, Inc.$572
- Sanofi$425
- Novartis$189
- AbbVie$180
- plus $814 from 18 others
What the payments were for
- Food & beverage$3,73298%
- Education$672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 44 | $846 |
| AstraZeneca | 24 | $773 |
| Regeneron Healthcare Solutions, Inc. | 33 | $572 |
| Sanofi | 12 | $425 |
| Novartis | 10 | $189 |
| AbbVie | 5 | $180 |
| Pfizer | 5 | $119 |
| Aerin Medical Inc. | 1 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| Biocryst US Sales Co., LLC | 3 | $86 |
| CSL Behring | 3 | $70 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $56 |
| Grifols USA, LLC | 3 | $46 |
| Amgen | 1 | $34 |
| Genentech USA, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $25 |
| Aurinia Pharma U.S., Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Ionis Pharmaceuticals, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
| GC Biopharma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$341
- FASENRA$125
- TEZSPIRE$120
- NUCALA$118
- VIVAER STYLUS$105
- RHINAER STYLUS$105
How this compares
Too few allergy providers in Louisianato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 109 | $1,748 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 13 | $1,333 |
| Levocetirizine Dihydrochloride | 38 | $523 |
| Azelastine Hcl | 27 | $475 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 31 | $406 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $404 |
| Famotidine | 25 | $160 |
| Methylprednisolone | 22 | $143 |
| Triamcinolone Acetonide | 11 | $119 |
| Omeprazole | 12 | $111 |
| Prednisone | 28 | $86 |
| Hydroxyzine Hcl | 12 | $82 |
Paid to pharmacies, not to this prescriber.
Other allergy in Hammond
- Jessica OchsnerMetairie$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.